DEP gemcitabine (Starpharma Holdings)

N/A

Report date: 2025/01/19 10:52:15

Base Information

Drug NameDEP gemcitabine (Starpharma Holdings)

Drug Alias NameDEP gemcitabine

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA synthesis inhibitorsCell cycle inhibitors

TargetsUpdating

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New ZealandUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesStarpharma Pty Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A